首页> 外国专利> The monoclonal antibody cancer-related genes mina53, proteins and Mina53

The monoclonal antibody cancer-related genes mina53, proteins and Mina53

机译:单克隆抗体癌症相关基因mina53,蛋白质和Mina53

摘要

Myc protein is a ubiquitous mediator of cell proliferation, I activate gene expression through E- box. If you are encoding a protein with a molecular weight of 53kDa, mina53 gene is present in the nucleolus and in the nucleoplasm. When the cells in the stationary phase is activated by serum, following the increase in the levels of c-myc mRNA, mina53mRNA increased. When in HL60 cells in human promyelocytic leukemia, the expression of c-myc were decreased by TPA, protein mina53mRNA decreased. Instead of mutant c-Myc lacking the activation domain, ectopic expression of wild-type c-Myc was increased expression of mina53. Protein expression and mina53mRNA can also be induced by artificial introduction of the activity of c-Myc. In addition, when the c-Myc of c-MycER chimeric protein during activated, mina53mRNA increases inhibitor on protein synthesis even in the presence of. On the other hand, there is a box E- site close to the transcription start site of the gene mina53, expression from mina53 promoter is activated by c-Myc via E- box. rather than after TPA treatment, c-Myc protein is bound to the promoter region mina53 vivo in HL60 growth phase in (in vivo). Moreover, specific inhibition of mina53 expression in rat 3Y1 cells fibroblasts having a HeLa cells, the c-myc with high expression significantly inhibits cell proliferation. Combining these results, mina53 is a Myc target gene, and shows the relationship to cell proliferation in mammals. Also, it is possible to specifically recognize the protein Mina53 cancer cells, is expressed in tissues or cells of esophageal cancer and colon cancer in particular, anti Mina53 monoclonal antibodies, used for the diagnosis of cancer diseases can be.
机译:Myc蛋白是细胞增殖的普遍介体,我通过E-box激活基因表达。如果您要编码分子量为53kDa的蛋白质,则mina53基因存在于核仁和核质中。当固定相中的细胞被血清激活时,随着c-myc mRNA水平的增加,mina53mRNA也随之增加。当在人早幼粒细胞白血病的HL60细胞中,TPA降低了c-myc的表达,mina53mRNA蛋白降低了。代替缺少活化域的突变c-Myc,野生型c-Myc的异位表达是mina53表达的增加。也可以通过人工引入c-Myc活性来诱导蛋白质表达和mina53mRNA。此外,当c-MycER嵌合蛋白的c-Myc在活化过程中,即使在存在下,mina53mRNA也会增加蛋白合成的抑制剂。另一方面,在基因mina53的转录起始位点附近有一个框E位,c-Myc通过E-box激活了来自mina53启动子的表达。而不是在TPA处理之后,c-Myc蛋白在HL60生长阶段(体内)结合到了mina53启动子区域。此外,在具有HeLa细胞的大鼠3Y1细胞成纤维细胞中,mina53表达的特异性抑制,高表达的c-myc显着抑制细胞增殖。结合这些结果,mina53是Myc靶基因,并显示与哺乳动物细胞增殖的关系。而且,可以特异性地识别在食道癌和结肠癌的组织或细胞中表达的蛋白Mina53癌细胞,特别是可以用于诊断癌症的抗Mina53单克隆抗体。

著录项

  • 公开/公告号JPWO2003087363A1

    专利类型

  • 公开/公告日2005-08-18

    原文格式PDF

  • 申请/专利权人 学校法人 久留米大学;

    申请/专利号JP20030584305

  • 发明设计人 常岡 誠;木村 博司;

    申请日2003-04-14

  • 分类号C12N15/09;C07K14/82;C07K16/32;C12Q1/02;G01N33/53;G01N33/574;G01N33/577;

  • 国家 JP

  • 入库时间 2022-08-21 22:27:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号